EN
中文 EN
  • 650+

    Peer-reviewed Articles

    UP TO 2026.06

  • 4700+

    lmpact Factor

  • 25+

    Tumor Types Involved

Cell Oncol (Dordr). | Mar-2026
Integrated analysis identifies a CXCR6/CD45/PD-1-based risk model for melanoma prognosis and intratumoral CD8+/CD69 + T-cell infiltration correlation
Melanoma
Learn More
Journal of Thoracic Oncology | Mar-2026
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study
OncoCompass Target (168‑gene panel) | NSCLC
Learn More
J Thorac Dis. | Apr-2026
Comprehensive characterization of non-small cell lung cancer of different PD-L1 expression classes: a study of 1,038 Chinese patients
OncoCompass Plus (520‑gene panel);OncoCompass Target (168‑gene panel); OncoCompass Focus (8‑gene panel) | NSCLC
Learn More
Oncol Lett. | May-2026
A novel prognostic biomarker combining TP53 loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy

OncoCompass Core (56‑gene panel) | Lung Squamous Cell Carcinoma

Learn More
Signal Transduction and Targeted Therapy |Feb-2026
First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFRmutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial

NSCLC

Learn More
1 2 3 4 5 6 7 8 9 10 ...
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."